ELOCTATE
ELOCTATE
Approved
DIN Number
02430304
Drug Class
Human
Market Date
Jan 15, 2016
Company
HC
sanofi-aventis canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02430304
AIG Number0155970002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
B02BD02 COAGULATION FACTOR VIII
Product Specifications
Dosage FormKit
,
Powder For Solution
Route of AdministrationIntravenous
AHFS Classification20:28.16
Health Canada Classification
ACTIVE INGREDIENTS (1)
ANTIHEMOPHILIC FACTOR (RECOMBINANT BDD), FC FUSION PROTEINActive
Strength: 500 UNIT / VIAL
Monograph: ANTIHEMOPHILIC FACTOR (RECOMBINANT BDD), FC FUSION PROTEIN